IL1RL2
Basic information
Region (hg38): 2:102187006-102240002
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the IL1RL2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 32 | 37 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 32 | 5 | 2 |
Variants in IL1RL2
This is a list of pathogenic ClinVar variants found in the IL1RL2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-102187575-C-A | Ascending aortic dissection | association (Feb 01, 2021) | ||
2-102189103-A-T | not specified | Uncertain significance (Feb 16, 2023) | ||
2-102189142-G-A | not specified | Uncertain significance (Oct 26, 2022) | ||
2-102189270-A-G | not specified | Uncertain significance (Jun 16, 2023) | ||
2-102189274-A-T | not specified | Uncertain significance (May 17, 2023) | ||
2-102189285-T-A | not specified | Uncertain significance (Oct 13, 2023) | ||
2-102191996-T-C | not specified | Uncertain significance (May 03, 2023) | ||
2-102192068-G-T | not specified | Uncertain significance (Jul 14, 2023) | ||
2-102192082-C-T | not specified | Uncertain significance (Jun 07, 2024) | ||
2-102192104-C-A | not specified | Uncertain significance (Feb 17, 2024) | ||
2-102212160-T-C | Benign (Jul 13, 2018) | |||
2-102219021-G-T | not specified | Uncertain significance (Feb 28, 2024) | ||
2-102219028-A-G | not specified | Uncertain significance (Aug 14, 2023) | ||
2-102219074-A-C | not specified | Uncertain significance (Nov 23, 2021) | ||
2-102219892-C-T | not specified | Uncertain significance (Apr 24, 2024) | ||
2-102219897-C-T | not specified | Uncertain significance (Jul 12, 2023) | ||
2-102219907-A-G | not specified | Uncertain significance (Dec 12, 2023) | ||
2-102219930-T-C | not specified | Uncertain significance (Nov 03, 2022) | ||
2-102219945-A-T | not specified | Uncertain significance (Sep 16, 2021) | ||
2-102219947-G-T | not specified | Uncertain significance (Mar 29, 2022) | ||
2-102220003-T-C | not specified | Uncertain significance (Oct 30, 2023) | ||
2-102225901-C-T | not specified | Uncertain significance (Dec 21, 2022) | ||
2-102225927-G-A | not specified | Uncertain significance (Dec 01, 2022) | ||
2-102225931-T-C | not specified | Uncertain significance (Jun 16, 2024) | ||
2-102225936-G-A | not specified | Uncertain significance (Nov 18, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
IL1RL2 | protein_coding | protein_coding | ENST00000264257 | 11 | 53030 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
3.54e-11 | 0.746 | 125580 | 2 | 166 | 125748 | 0.000668 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.436 | 303 | 325 | 0.932 | 0.0000174 | 3759 |
Missense in Polyphen | 82 | 84.176 | 0.97415 | 1016 | ||
Synonymous | -1.71 | 154 | 129 | 1.19 | 0.00000791 | 1086 |
Loss of Function | 1.61 | 21 | 30.6 | 0.687 | 0.00000162 | 360 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00103 | 0.00103 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000164 | 0.000163 |
Finnish | 0.0000929 | 0.0000924 |
European (Non-Finnish) | 0.000292 | 0.000290 |
Middle Eastern | 0.000164 | 0.000163 |
South Asian | 0.00354 | 0.00344 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Receptor for interleukin-36 (IL36A, IL36B and IL36G). After binding to interleukin-36 associates with the coreceptor IL1RAP to form the interleukin-36 receptor complex which mediates interleukin-36-dependent activation of NF-kappa-B, MAPK and other pathways (By similarity). The IL-36 signaling system is thought to be present in epithelial barriers and to take part in local inflammatory response; it is similar to the IL-1 system. Seems to be involved in skin inflammatory response by induction of the IL- 23/IL-17/IL-22 pathway. {ECO:0000250|UniProtKB:Q9ERS7, ECO:0000269|PubMed:11466363}.;
- Pathway
- Signaling by Interleukins;Cytokine Signaling in Immune system;Immune System;Interleukin-36 pathway;Interleukin-38 signaling;Interleukin-1 family signaling
(Consensus)
Recessive Scores
- pRec
- 0.103
Intolerance Scores
- loftool
- 0.900
- rvis_EVS
- -0.17
- rvis_percentile_EVS
- 40.6
Haploinsufficiency Scores
- pHI
- 0.0909
- hipred
- N
- hipred_score
- 0.132
- ghis
- 0.492
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0684
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Il1rl2
- Phenotype
- normal phenotype; hematopoietic system phenotype; immune system phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- inflammatory response;cellular defense response;signal transduction;cytokine-mediated signaling pathway;positive regulation of interleukin-6 production;innate immune response;positive regulation of T cell differentiation;regulation of inflammatory response;interleukin-1-mediated signaling pathway;cellular response to cytokine stimulus
- Cellular component
- plasma membrane;integral component of plasma membrane
- Molecular function
- interleukin-1 receptor activity;interleukin-1, type I, activating receptor activity